T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
CAVA Group
CAVA
$8.2B
| $126M | 0.01% |
1,116,649
-449,497
| -29% | -$59.9M |
|
527
Petrobras
PBR
$115B
| $126M | 0.01% |
9,790,462
+2,822,641
| +41% | +$39.4M |
|
528
Cytokinetics
CYTK
$10.4B
| $123M | 0.01% |
2,625,081
-539,864
| -17% | -$28M |
|
529
Ero Copper
ERO
$3.62B
| $123M | 0.01% |
9,112,791
-57,086
| -0.6% | -$967K |
|
530
Warrior Met Coal
HCC
$5.05B
| $123M | 0.01% |
2,259,608
+117,717
| +5% | +$7.52M |
|
531
Alamos Gold
AGI
$13.7B
| $122M | 0.01% |
6,638,742
-1,234,890
| -16% | -$23.9M |
|
|
DOO
532
Bombardier Recreational Products
DOO
$4.74B
| $122M | 0.01% |
2,398,765
-65,010
| -3% | -$3.38M |
|
533
Galicia Financial Group
GGAL
$7.06B
| $122M | 0.01% |
1,955,180
-453,996
| -19% | -$25M |
|
|
AKRO
534
DELISTED
Akero Therapeutics
AKRO
| $120M | 0.01% |
4,321,972
+513,613
| +13% | +$15.6M |
|
535
FirstService
FSV
$6.05B
| $119M | 0.01% |
656,097
+229,889
| +54% | +$43M |
|
|
SWTX
536
DELISTED
SpringWorks Therapeutics
SWTX
| $118M | 0.01% |
3,274,786
-241,632
| -7% | -$8.44M |
|
537
Truist Financial
TFC
$64.6B
| $118M | 0.01% |
2,721,370
-5,935
| -0.2% | -$265K |
|
538
Amcor
AMCR
$21.5B
| $118M | 0.01% |
2,498,525
+17,196
| +0.7% | +$898K |
|
539
W.W. Grainger
GWW
$61.6B
| $117M | 0.01% |
111,073
+48,889
| +79% | +$55.1M |
|
540
Arthur J. Gallagher & Co
AJG
$64.4B
| $117M | 0.01% |
412,304
+32,156
| +8% | +$9.36M |
|
541
Summit Therapeutics
SMMT
$11.9B
| $117M | 0.01% |
6,557,927
+1,118,270
| +21% | +$21.7M |
|
542
United Airlines
UAL
$41.2B
| $117M | 0.01% |
1,202,740
-11,950
| -1% | -$1.01M |
|
|
CCC
543
CCC Intelligent Solutions
CCC
$4B
| $115M | 0.01% |
9,837,354
+9,607,085
| +4,172% | +$111M |
|
544
Murphy USA
MUSA
$10.2B
| $115M | 0.01% |
229,112
-6,560
| -3% | -$3.35M |
|
545
Affirm
AFRM
$25.3B
| $115M | 0.01% |
1,887,058
+126,320
| +7% | +$7.02M |
|
546
NetEase
NTES
$78.1B
| $114M | 0.01% |
1,280,643
+135,180
| +12% | +$11.8M |
|
547
PNC Financial Services
PNC
$102B
| $113M | 0.01% |
588,427
-345,358
| -37% | -$67.9M |
|
548
Live Nation Entertainment
LYV
$43.3B
| $112M | 0.01% |
865,871
+268,857
| +45% | +$33.8M |
|
549
Corteva
CTVA
$50.4B
| $112M | 0.01% |
1,961,440
+967,118
| +97% | +$57.2M |
|
550
Futu Holdings
FUTU
$14.5B
| $109M | 0.01% |
1,368,627
-280,076
| -17% | -$26.2M |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.